T

The Biological Computing Co.

Living neural networks augment AI models

Overview

The Biological Computing Co. combines living neurons with silicon-based AI to improve performance on tasks like computer vision and generative video. It encodes real-world data into living neurons, records their activity, and decodes it into richer representations that are then fed into AI models through modular Biological Adapters, with an accompanying Algorithm Discovery platform. Unlike competitors that rely on silicon-only approaches, it uses wetware and biological signals to augment AI, plus adapters that translate neural data for current models. Its goal is to provide bio-computing infrastructure that boosts AI accuracy and efficiency, reduces training needs, and supports learning beyond traditional transformer-based systems.

Work here?Claim your company

About The Biological Computing Co.

Simplify's Rating
Why The Biological Computing Co. is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsAI & Machine LearningBiotechnologyHealthcare

Company Size

11-50

Company Stage

Seed

Total Funding

$25M

Headquarters

San Francisco, CA

Founded

2022

Get referred to The Biological Computing Co.

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • AWS listed TBC’s model on Trainium and SageMaker, opening enterprise distribution in 2026.
  • Atish Banerjea joined October 5, 2026, strengthening infrastructure and partnership credibility.
  • TIME named TBC a Best Invention on October 15, 2026, boosting hiring and customer trust.

What critics are saying

  • Mischief 1 lacks published independent benchmarks, inviting customer skepticism after October 30, 2026.
  • Cortical Labs' August 2026 biological data center proves rivals can productize living-neuron compute first.
  • If neuron-derived gains stay incremental, TBC becomes a novelty vendor and misses broad AI adoption.

What makes The Biological Computing Co. unique

  • TBC converts neuron measurements into software adapters, not customer-facing wet labs, unlike Cortical Labs.
  • September 22, 2026 AWS collaboration puts TBC on conventional infrastructure, easing enterprise adoption.
  • Mischief 1, launched October 30, 2026, commercializes biological compute as a usable video product.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$25M

Above

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
$2.3M
$3M
$25M

Growth & Insights and Company News

6 month growth

-2%

1 year growth

-5%

2 year growth

-5%
OfficeChai
Oct 31st, 2026
The Biological Computing Co. launches Mischief 1, an AI video model trained on lessons from living neurons.

The Biological Computing Co. launches Mischief 1, an AI video model trained on lessons from living neurons. Newer AI approaches aren't just innovating with different architectures - they're innovating on the substrate itself. San Francisco startup The Biological Computing Co. (TBC) has released its first commercial AI product, an image-to-video model called Mischief 1, fittingly timed to Halloween. CEO and co-founder Alex Ksendzovsky announced the launch on X, calling it a "little mischief" four years in the making. "For four years, we've been brewing real brain cells on electrodes to understand how they compute. Now, we've turned those discoveries into a video model anyone can use," Ksendzovsky wrote. He said Mischief 1 is at least 5x faster than its base model and the cheapest image-to-video model available on both fal and OpenRouter, starting at 0.5 cents a second, with an AWS Marketplace listing coming soon. What TBC actually does. TBC's core business isn't video generation - it's biological computing. The company grows living neurons, derived from stem cells, on multi-electrode arrays in its lab and studies how those cells naturally process and compute information. Real-world data like text, images, and video gets encoded into the neurons, and the resulting neural activity is decoded back out and mapped onto conventional AI architectures as an optimization layer. The pitch is that half a billion years of evolution has already solved problems around efficiency and adaptability that silicon is still struggling with, and that borrowing those biological computing principles can make transformer-based models faster and cheaper to run without replacing the underlying hardware. Mischief 1 is the company's first attempt to put that research into a product anyone can actually use, rather than a research demo. It's a similar instinct to the one driving work on direct brain-computer interfaces, where companies are trying to find ways for biological and digital systems to communicate directly with each other - except TBC is going the other way, using biology to make the computing itself more efficient rather than connecting it to a human user. The founders. TBC was founded by Alex Ksendzovsky and Jon Pomeraniec, who serve as CEO and COO/President respectively. Both are trained neurosurgeons rather than typical Silicon Valley software founders - Ksendzovsky and Pomeraniec met as undergraduates at the University of Maryland and the University of Pennsylvania and have maintained a two-decade partnership through medical school, surgical residencies, and academic research roles. Ksendzovsky has said the idea traces back to his college years, when he was studying philosophy of mind and watched a visiting professor demonstrate a robot powered by a single neuron, which convinced him there was untapped computational power in biological tissue. The pair reportedly made early research progress on the brain's computing capabilities around 2021 before leaving academic and surgical careers to start the company, initially operating under the name Biological Black Box before rebranding to The Biological Computing Co. Funding. TBC emerged from stealth in February 2026 with a $25 million seed round led by Primary Venture Partners, alongside Builders VC, E1 Ventures, Proximity, Refactor Capital, Tusk Venture Partners, and Wonder Ventures. The round coincided with the opening of the company's flagship wet lab in San Francisco's Mission Bay neighborhood, where its neuron-electrode chips are grown and maintained. Primary's Brian Schechter, who led the investment, has argued that silicon has "carried the field far" but that AI's next efficiency breakthrough will need to come from alternative architectures like biological computing. Tim Gardner, a co-founder of Neuralink, is among the backers who have publicly endorsed TBC's direction, saying the most performant compute of the future will likely resemble the brain more than today's chips do. TBC has said its neurons are sourced through established, lawful biomedical supply chains, and that it is moving away from rat-derived cells toward neurons grown from reprogrammed human stem cells. Each chip reportedly houses between 100,000 and 500,000 neurons and has a working lifespan of about a year. Where this fits. TBC isn't alone in trying to commercialize biological computing - Melbourne's Cortical Labs has pursued a similar living-neuron approach and recently opened what it calls the world's first biological data centre in partnership with Singapore's NUS Medicine and data-centre developer DayOne. But TBC appears to be the first to ship a neuron-derived optimization into a publicly available commercial AI product rather than a research platform, with Mischief 1 live on fal and OpenRouter today and an AWS Marketplace listing expected to follow.

PR Newswire
Oct 30th, 2026
TBC launches neuron-derived AI video model that generates 5x faster at $0.005 per second

The Biological Computing Co. (TBC), a San Francisco company that uses living neurons to improve AI models, has launched mischief 1, an AI video model that generates video 5x faster than its base model. It is available on fal and OpenRouter, where TBC says it is the lowest-priced image-to-video model. The model is built on Wan 2.2, an open-weight video model, and matches its quality. TBC says it applied efficiencies found by measuring living neurons in the lab. Customers run only software on standard AI hardware, and the neurons stay in the lab. Pricing is half a cent per second, so a five-second clip costs 2.5 cents and 100 clips cost $2.50. TBC is applying the process to newer video models and is developing uses in language models and physical AI.

PR Newswire
Oct 15th, 2026
TBC's neuron-derived AI video technology named to TIME's Best Inventions of 2026

The Biological Computing Co. (TBC), a San Francisco company that uses living neurons to improve AI models, has been named to TIME's Best Inventions of 2026. The company announced the recognition on October 15, 2026. The award honours a software adapter, TBC's first commercial product. It applies findings on how living neurons process information to make existing AI video models faster and cheaper to run, on the same silicon and infrastructure customers already use. "The brain is the most efficient computer we know, and we're learning directly from it to build better AI," said Alex Ksendzovsky, co-founder and chief executive officer. He said the platform could extend beyond video to other AI models. TIME judges entries on originality, efficacy, ambition, and impact.

San Francisco Biotechnology Network
Oct 5th, 2026
Former meta and NBC universal CIO atish banerjea joins The Biological Computing Co. (TBC) as strategic advisor.

Former meta and NBC universal CIO atish banerjea joins The Biological Computing Co. (TBC) as strategic advisor. Banerjea will help TBC define the infrastructure roadmap from neuron-derived AI inference optimization to real-time inference and biological compute SAN FRANCISCO, Oct. 5, 2026 /PRNewswire/ - The Biological Computing Co. (TBC), an applied biological computing company that uses real...

PR Newswire
Oct 5th, 2026
Former Meta CIO Atish Banerjea joins biological computing startup TBC as strategic advisor

The Biological Computing Co. (TBC) has appointed Atish Banerjea, former CIO of Meta and NBCUniversal, as Strategic Advisor for Real-Time Inference and Biological Compute. Banerjea will help define TBC's infrastructure roadmap from neuron-derived AI optimisation to biological computing systems where real neurons work alongside silicon. TBC uses real neurons in its discovery process to improve AI models, starting with generative video and world models. The company has raised $52.5 million to date, including a $25 million seed extension led by Builders VC, with Wonder Ventures, Jeff Dean, and Tusk Ventures participating. Banerjea will establish a roadmap covering systems architecture, infrastructure strategy, and technical milestones, whilst advising on partnerships with cloud providers and hardware partners.

Recently Posted Jobs

Sign up to get curated job recommendations

The Biological Computing Co. is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs